What are the clinical challenges in the use of biomarkers to estimate the risk of a cardiovascular event?
Join Dr Bruna Gigante (Karolinska Institute, Solna, SE) in a discussion of potential biomarkers which may impact a patient’s cardiovascular risk profile. In this month’s featured author episode of the ECR Podcast, Dr Gigante discusses novel biomarkers a ... Show More
Oct 2025
NVM Cardiology Meeting Reflections: TCT 25 Wrap Up
In this Redcliffe Cardiology NVM reflections episode, Prof Nicolas Van Mieghem cuts through the noise from TCT 2025. Tune in to hear what the SELUTION trials mean for drug-coated balloons in de novo disease and ISR, why cost and sizing matter in calcium modification, how PE throm ... Show More
33m 19s
Oct 2025
TCT 25 Structural Interventions Highlights: Real-World Outcomes and Latest Trial Updates
At TCT 2025, Dr Nadira Hamid (Minneapolis Heart Institute, US) and Dr. Rahul P. Sharma (Stanford University, US) review the late-breaking trial data shaping the future of structural heart disease. The discussion highlights real-world results from TRISCEND and TRILUMINATE in tricu ... Show More
21m 50s
Sep 2025
View from the Thoraxcenter: ESC 25 Late-breaking Science Wrap-Up
Explore ESC 25 Top Trials with Insights from the Thoraxcenter! Join Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC, Rotterdam, for an engaging and critical analysis of the latest trials unveiled at ESC 2025. In this comprehensive ESC wrap-up, interventional experts ... Show More
47m 54s
Sep 2025
AI, Polygenic Risk Scores, and Antithrombotic Therapy | JACC This Week
In this episode, Editor-in-Chief Harlan Krumholz explores the evolving landscape of cardiovascular medicine, beginning with a call for responsible stewardship of artificial intelligence. Highlights include a major registry study on percutaneous aspiration for right-sided endocard ... Show More
9m 54s
Apr 2025
Ep 203 Intermediate Risk Pulmonary Embolism Risk Stratification, Management and Algorithm
How do you predict which intermediate-risk patients will suddenly deteriorate? What role do risk scores, biomarkers, imaging, and hemodynamics play in decision-making? Should these patients receive anticoagulation alone, or is thrombolysis warranted? When should you consider cath ... Show More
1h 35m